Overview

Public BiotechPhase 3MDMALSDpsilocybinOther

Spun out from MAPS to develop MDMA-assisted therapy. After FDA declined approval in August 2024, underwent significant restructuring. Continuing to pursue MDMA therapy for PTSD.

Visit Website

San Jose, CA

2024
Founded
60
Employees
0
Open Roles

Open Positions

No open positions at this time

Research Areas

Clinical Pipeline(30)

Completed·Phase 2·MDMA

Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial

MidomafetaminePosttraumatic Stress Disorder
Completed·Phase 2·MDMA

Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

MidomafetaminePTSD
Completed·Phase 2·MDMA

MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

Midomafetamine HClAnxiety
Withdrawn·Phase 2·MDMA

A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders

MidomafetamineAnorexia Nervosa Restricting Type
Completed·Phase 1·MDMA

Food Effects on Bioavailability of MDMA in Healthy Volunteers

midomafetaminePharmacokinetics
Not Yet Recruiting·Phase 1·MDMA

MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function

Midomafetamine HClPharmacokinetics
Completed·Phase 1·MDMA

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers

Lactose (inactive placebo)Psychological Effects of Study Drug
Completed·Phase 3·MDMA

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

TherapyPosttraumatic Stress Disorder
Withdrawn·Phase 2·MDMA

Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

midomafetaminePosttraumatic Stress Disorder
Completed·Phase 2·MDMA

Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults

PlaceboSocial Anxiety in Autistic Adults
Completed·Phase 2·MDMA

Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD

Comparator Dose (40mg) MDMA HClPosttraumatic Stress Disorder
Withdrawn·Phase 2·MDMA

Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans

MidomafetaminePTSD
Completed·N/A·MDMA

Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD

PTSD
Completed·N/A·MDMA

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

MidomafetaminePosttraumatic Stress Disorder
Completed·Phase 2·MDMA

Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study

Midomafetamine HClPTSD
Terminated·Phase 2·MDMA

Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD

PlaceboPosttraumatic Stress Disorder
Completed·Phase 2·LSD

Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety

200 mcg LSDAnxiety
No Longer Available·N/A·MDMA

A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD

MidomafetaminePost Traumatic Stress Disorder
Completed·Phase 3·MDMA

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)

TherapyPosttraumatic Stress Disorder
Completed·Phase 2·MDMA

Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)

Midomafetamine HClPosttraumatic Stress Disorder
Completed·Phase 3·MDMA

A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD

Midomafetamine HClPTSD
Completed·Phase 1·MDMA

Evaluation of MDMA on Startle Response

PlaceboStartle Response
Withdrawn·Phase 2·psilocybin

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

psilocybinAnxiety
Completed·N/A·Other

Correlates of Anxiety Associated With a Life-threatening Illness

fMRIAnxiety
Completed·Phase 2·MDMA

Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder

Low dose MDMA-assisted therapyPosttraumatic Stress Disorder
Completed·Phase 2·MDMA

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Midomafetamine HClPosttraumatic Stress Disorder
Terminated·Phase 2·MDMA

Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD

MidomafetaminePTSD
Completed·Phase 1·MDMA

MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

MDMAPosttraumatic Stress Disorder
Completed·Phase 2·MDMA

Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder

3,4-methylenedioxymethamphetamine (125 mg)Posttraumatic Stress Disorder
Withdrawn·Phase 1·MDMA

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

Midomafetamine HClPsychological Effects of Study Drug